Market Overview - U.S. stock futures are higher, with Dow futures gaining approximately 0.1% on Wednesday [1] GitLab Inc (NASDAQ:GTLB) - GitLab reported quarterly earnings of $0.25 per share, surpassing the analyst estimate of $0.20 [2] - Quarterly revenue reached $244.35 million, exceeding the Street estimate of $239.63 million [2] - Despite the positive earnings and revenue, GitLab shares fell 8% to $39.90 in pre-market trading due to fourth-quarter sales guidance being below estimates [2] Acadia Healthcare Company Inc (NASDAQ:ACHC) - Acadia Healthcare's shares dropped 22.7% to $12.74 in pre-market trading after the company reduced its full-year 2025 guidance [4] - The reduction was attributed to increased expenses related to patient-related litigation, leading to updates in professional and general liability reserves [4] TryHard Holdings Limited (NASDAQ:THH) - TryHard Holdings experienced a decline of 16.6% to $18.70 in pre-market trading after a significant increase of 50% on the previous day [4] Pure Storage Inc (NYSE:PSTG) - Pure Storage shares fell 11.8% to $83.50 in pre-market trading following the release of its quarterly results [4] Box Inc (NYSE:BOX) - Box's shares decreased by 7.1% to $28.05 in pre-market trading after posting in-line earnings for the third quarter but providing fiscal 2026 EPS guidance below analyst estimates [4] Okta, Inc. (NASDAQ:OKTA) - Okta's shares declined 3.5% to $79.03 in pre-market trading after the company reported third-quarter results [4] Erasca, Inc. (NASDAQ:ERAS) - Erasca's shares fell 2.8% to $2.81 in pre-market trading, following a 4% decline on the previous day [4] CrowdStrike Holdings, Inc. (NASDAQ:CRWD) - CrowdStrike's shares slipped 2.1% to $505.79 in pre-market trading despite reporting better-than-expected financial results for the third quarter and raising its full-year guidance [4]

Market Overview - U.S. stock futures rose on Wednesday following modest advances on Tuesday, with major benchmark indices showing higher futures [1] - The 10-year Treasury bond yielded 4.08%, while the two-year bond was at 3.49%, with an 87% likelihood of the Federal Reserve cutting interest rates in December [2] - Key index performances included Dow Jones up 0.21%, S&P 500 up 0.16%, Nasdaq 100 up 0.10%, and Russell 2000 up 0.37% [2] Company Performance - Marvell Technology Inc. (NASDAQ:MRVL) surged 9.83% after reporting better-than-expected third-quarter results and announcing the acquisition of Celestial AI [6] - CrowdStrike Holdings Inc. (NASDAQ:CRWD) fell 2.36% despite exceeding financial expectations for the third quarter and raising full-year guidance [6] - American Eagle Outfitters Inc. (NYSE:AEO) increased by 12.71% after reporting third-quarter revenue of $1.36 billion, surpassing analyst estimates of $1.32 billion, and adjusted earnings of 53 cents per share, beating estimates of 44 cents [6] Analyst Insights - BlackRock maintains a "pro-risk" investment stance, favoring U.S. equities as a softening labor market allows for potential Federal Reserve rate cuts [10] - The firm describes the current employment landscape as a "no hiring, no firing" situation, which could enable the Fed to pursue "risk management" cuts without reigniting inflation [10] - BlackRock believes the Fed has room to ease policy without raising concerns about inflation and debt sustainability, supporting a positive outlook for risk assets into 2026 [12]

Market Overview - U.S. stock futures rose on Wednesday following modest advances on Tuesday, with major benchmark indices showing higher futures [1] - The 10-year Treasury bond yielded 4.08%, while the two-year bond was at 3.49%, with an 87% likelihood of the Federal Reserve cutting interest rates in December [2] - Key index performances included Dow Jones up 0.21%, S&P 500 up 0.16%, Nasdaq 100 up 0.10%, and Russell 2000 up 0.37% [2] Company Performance - **Marvell Technology Inc. (NASDAQ:MRVL)** saw a significant increase of 9.83% after reporting better-than-expected third-quarter results and announcing the acquisition of Celestial AI [6] - **CrowdStrike Holdings Inc. (NASDAQ:CRWD)** dropped 2.36% despite exceeding financial expectations for the third quarter and raising its full-year guidance [6] - **American Eagle Outfitters Inc. (NYSE:AEO)** climbed 12.71% after reporting third-quarter revenue of $1.36 billion, surpassing analyst estimates of $1.32 billion, and adjusted earnings of 53 cents per share, beating estimates of 44 cents [6] - **Salesforce Inc. (NYSE:CRM)** was up 0.55% as analysts expect quarterly earnings of $2.86 per share on revenue of $10.27 billion [5] Analyst Insights - BlackRock maintains a "pro-risk" investment stance, favoring U.S. equities due to a softening labor market that may allow for further Federal Reserve rate cuts [10] - The firm describes the current employment landscape as a "no hiring, no firing" stasis, which supports the Fed's ability to pursue "risk management" cuts without reigniting inflation [10] - BlackRock believes the Fed has room to ease policy without raising concerns about inflation and debt sustainability, supporting a positive outlook for risk assets heading into 2026 [12]

Group 1 - Acadia Healthcare (ACHC.US) experienced a pre-market drop of over 22% following a downward revision of its 2025 guidance [1] - The adjusted EBITDA forecast for 2025 was lowered to a range of $601 million to $611 million [1] - Earnings per share (EPS) guidance was reduced by $0.41, now expected to be between $1.94 and $2.04 due to increased professional and general liability costs [1] Group 2 - The company anticipates PLGL expenses for 2025 to be approximately $116 million, which represents an increase of about $62 million compared to $54 million in 2024 [1]

In the current session, Acadia Healthcare Co Inc. (NASDAQ:ACHC) is trading at $12.45, after a 26.07% drop. Over the past month, the stock fell by 20.18%, and in the past year, by 60.89%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. Evaluating Acadia Healthcare Co P/E in Comparison to Its PeersThe P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current ...

Group 1 - Acadia Healthcare Company Inc. is considered a cheap stock to buy according to analysts, with KeyBanc lowering its price target to $30 from $35 while maintaining an Overweight rating [1][3] - In Q3 2025, Acadia Healthcare reported a revenue increase of 4.4%, totaling $851.6 million, supported by a 3% growth in same facility admissions [2][3] - The company's adjusted EBITDA for Q3 decreased to $173 million from $194.3 million in the prior year, leading to a reduction in Adjusted EBITDA guidance for 2025 to a range of $650 to $660 million [3]

Core Viewpoint - The company has agreed to settle shareholder litigation for $179 million without admitting any wrongdoing, aiming to resolve a long-standing legal issue dating back to 2018 [1][2]. Group 1: Settlement Details - The settlement amount is $179 million, expected to be finalized by the end of November [2]. - The payment will be funded through a combination of approximately $30 million [2]. Group 2: Background of the Case - The litigation stems from allegations of misleading statements regarding the company's business and financial performance from April 2014 to the end of 2018 [2]. - The company has consistently denied any wrongdoing throughout the litigation process [1].

Acadia Healthcare Company Conference Call Summary Company Overview - **Company**: Acadia Healthcare Company (NasdaqGS: ACHC) - **Date**: November 11, 2025 - **Speakers**: Chris Hunter (CEO), Todd Young (CFO) Key Points Legal Settlement - Acadia Healthcare has agreed to settle shareholder litigation for **$179 million** without admitting fault or liability, which has been ongoing since **2018** regarding misleading statements about business performance from **April 2014 to end of 2018** [2][3] Financial Performance - Results for 2025 have been **modestly below expectations**, prompting a revision in guidance [4] - The company added **1,700 beds** over the past few years, with **632 beds** contributing to same-store calculations in Q1 2026 [4][5] - Net leverage is expected to increase from **3.4x to approximately 3.65x**, which is considered manageable [3] Growth Strategy - Acadia is focused on capital deployment, planning to reduce **CapEx by $300 million** while still generating significant bed additions [5] - The company aims to unlock free cash flow and improve margins by closing underperforming facilities [6][12] Volume Trends and Managed Care - There has been pressure from managed care companies, particularly regarding pre-authorizations, impacting revenue per patient day despite a **3.3% same-store admission increase** [9][10] - The average length of stay is decreasing due to an increase in acute beds, which typically have shorter stays [9] Future Guidance - The fourth quarter of 2025 is expected to show deterioration compared to Q3, influenced by volume softness and elevated bad debt [12] - Startup losses are anticipated to decline in 2026, with contributions from new bed additions expected to drive growth [13] Market Dynamics - Acadia is experiencing increased scrutiny from payers, particularly in behavioral health, which has historically seen underinvestment [17][18] - The company is actively engaging with payers to demonstrate the value of their investments in quality infrastructure [17] Facility Closures - Acadia closed **five underperforming facilities** in 2025, with ongoing reviews of the remaining **278 facilities** [23][24] - The closures were driven by shifting market dynamics and persistent underperformance [28] Labor and Expense Environment - The labor market is stabilizing, with base wage inflation decreasing slightly [30] - Employee retention has improved over six consecutive quarters, reflecting successful workforce initiatives [30] Liability Expenses - Professional and general liability expenses are expected to remain a headwind, with adjustments made for under-accrued expenses in Q4 [32][33] Supplemental Payment Programs - Acadia anticipates **$22 million** of EBITDA upside from pending supplemental payment programs, which could be recognized in Q4 or early 2026 [34] Public Health Funding - The company is monitoring cuts to the Substance Abuse and Mental Health Services Administration (SAMHSA) but currently sees limited direct exposure [36] - Acadia is tracking opioid settlement dollars and is well-positioned for future RFPs [38][39] Closing Remarks - The management expresses confidence in the company's long-term strategy and the potential for future cash flow generation from existing capital investments [41] Additional Insights - Acadia's focus on quality care and partnerships with joint ventures is seen as a key driver for future growth [20][25] - The company remains committed to addressing the needs of patients with behavioral health issues, leveraging investments to improve outcomes and manage costs effectively [18][19]

Core Insights - Acadia Healthcare Company, Inc. will participate in the UBS Global Healthcare Conference from November 9 to 12, 2025, in Palm Beach Gardens, Florida [1] - An online webcast of the Company's presentation will be available on its website starting at 1:45 p.m. Central Time on November 11, 2025 [2] - Acadia is a leading provider of behavioral healthcare services in the U.S., operating 278 facilities with approximately 12,500 beds across 40 states and Puerto Rico as of September 30, 2025 [3] Financial Performance - For the third quarter of 2025, Acadia reported revenue of $851.6 million, marking a 4.4% increase compared to the same quarter in 2024 [6] - Same facility revenue increased by 3.7% year-over-year, with revenue per patient day rising by 2.3% and patient days increasing by 1.3% [6]

Core Insights - Acadia Healthcare Company, Inc. (ACHC) reported adjusted third-quarter earnings of 72 cents per share, exceeding the Zacks Consensus Estimate by 7.5%, but reflecting a year-over-year decline of 20.9% [1][9] - Total revenues increased by 4.4% year over year to $851.6 million, slightly surpassing the consensus mark by 0.4% [1][9] Financial Performance - Same-facility revenues reached $827.8 million, a 3.7% increase year over year, but fell short of the Zacks Consensus Estimate by 1.4% [3] - Patient days increased by 1.3%, while admissions grew by 3.3% year over year [3] - Average length of stay decreased by 1.9% year over year, missing the consensus estimate by 3.2% [3] - Total expenses rose by 13.2% year over year to $811.6 million, driven by higher salaries, wages, benefits, and other operating costs [4] Cash and Debt Position - As of September 30, 2025, Acadia Healthcare had cash and cash equivalents of $118.7 million, up from $76.3 million at the end of 2024 [5] - Long-term debt increased to $2.3 billion from $1.9 billion as of December 31, 2024 [6] - Total equity rose to $3.1 billion compared to the end of 2024 [6] Share Repurchase and Guidance - Year-to-date share repurchases totaled $50.4 million, with no buyback activity in the third quarter [7] - 2025 revenue guidance was revised down to a range of $3.28 to $3.30 billion, and adjusted EBITDA is now estimated between $650 million and $660 million [8][10] Industry Comparison - HCA Healthcare reported adjusted EPS of $6.96, surpassing estimates by 23.2% and showing a 42% year-over-year improvement [12] - Universal Health Services reported adjusted EPS of $5.69, exceeding estimates by 22.1% and reflecting a 53.4% year-over-year increase [13] - Community Health Systems posted adjusted earnings of $1.27 per share, beating estimates and improving from a prior-year loss [14]